The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ritonavir 100 mg film-coated tablet



Accord Healthcare Ireland Ltd.PA2315/176/001

Main Information

Trade NameRitonavir 100 mg film-coated tablet
Active SubstancesRitonavir
Dosage FormFilm-coated tablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/176/001

Group Information

ATC CodeJ05AE Protease inhibitors
J05AE03 ritonavir

Status

License statusAuthorised
Licence Issued07/04/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back